Clinical Trial Update: Heart Rate Variability (HRV) in Patients With Neurogenic Detrusor Overactivity (NDO) Before and After Botulinum Neurotoxin Type A (BoNT/A) Intradetrusor Injections

View source ↗

Summary

This completed clinical trial evaluated heart rate variability in patients with neurogenic detrusor overactivity before and after intradetrusor injections of bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Neurogenic Detrusor Overactivity

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Balgrist University Hospital | Conditions: Bladder Disorder, Neurogenic | Status: COMPLETED